Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume, ASP & Number of Procedure Conducted by Catheter Type & Materials The global central venous catheter market will witness a robust CAGR of 5.48%, valued at $1.18 billion in 2021, expected to appreciate and reach $1.93 billion by 2030, confirms Strategic Market Research. Market Drivers - Rise of CVDs, Usage of Different Types of CVCs Leading to the Overall Market Growth The continuous rising prevalence of CVDs/cardiovascular diseases (coronary artery disease, atherosclerosis, cardiomyopathy, myocardial infarction, etc.) is one of the essential factors driving the overall market growth throughout 2020-2030. According to the AHA (American Heart Association), CVDs led to 868,662 deaths in 2017. In 2018, in the United States, CHD (coronary heart disease) was the primary cause of death (42.1%), followed by stroke (17.0%), high BP (11.0%), Cardiac failure (9.6%), arterial diseases (2.9%), and other CVDs (17.4%). Due to the uprise in the CVDs, the rise in usage of different types of CVCs like a percutaneous central venous catheter, subclavian vein catheter, femoral venous catheter, non-tunnelled percutaneous central venous catheter, triple lumen central venous catheter, subclavian central venous catheter, PICC line catheter, internal jugular vein catheter for dialysis, implanted port, etc. and processes like CVC line insertion, internal jugular vein catheterization, Chemotherapy, and kidney dialysis are widely augmenting the market growth efficiently. Further, the growing demand for antimicrobial catheters, rapid technological advancements and the rise in the geriatric population are boosting the overall market growth significantly. According to UNESA (United Nations Department of Economic and Social Affairs), in 2020, approximately there were 727Mn people aged 65 years or above across the world. The number is expected to increase to over 1.5 Bn by 2050. Restraints: - (Rise in the risk of infections) Factors such as deep venous thrombosis (DVT), infections, thrombophlebitis, and dislodgement due to the use of catheters are hindering the overall market growth. Opportunities:(Increase in expenditure on R&D activities all around the world) The demand for Central Venous Catheter is continuously increasing across the globe as it has some special benefits like the ability to deliver fluids into a larger vein and remain in the body for a longer period than usual. This rise in demand for these catheters and the increase of worldwide government funds in the R&D of surgical equipment are expected to create ample opportunities in the future. Central Venous Catheter Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 Market size value in 2021 USD 1.18 billion Revenue forecast in 2030 USD 1.93 billion Growth rate CAGR of 5.48 % The base year for estimation 2021 Historical data 2015 – 2019 Unit USD Billion, CAGR (2021 - 2030) Segmentation Based on Product Type, Based on Property, Based on Design, Based on Composition, Based on End-User and By region. Based on Product Type Non-Tunnelled Catheters, Tunnelled Catheters . Based on Property Non-Antimicrobial Catheters, Antimicrobial Catheters, Others Based on Design Multi Lumen, Double Lumen, Single Lumen. Based on Composition Polyurethane, Silicone, Others . Based on End-User Hospitals (Special Care Units, Intensive Care Units, and other hospital settings) ,Long-Term Care Facilities (LTCFs) , Outpatient Facilities . By Region North America, Europe, Asia-Pacific, and LAMEA Country Scope US, Mexico, Canada, Germany, UK, France, China, Japan, India etc. Company Usability Profiles Amecath, B. Braun Melsungen AG, Boston Scientific Corporation, AngioDynamics, Inc., BACTIGUARD, Cook Medical, Inc., Smiths Medical, Becton, Dickinson & Company, Biosensors International Group Ltd., BARD Care, ConMed Corporation, Edwards Lifesciences Corporation, Guangdong Baihe Medical Technology Co. Ltd., Intra Special Catheters GmbH, ISO-MED, INC., Henan Tuoren Medical Device Co. Ltd., Kimal PLC, Lepu Medical Technology (Beijing) Co. Ltd, Medical Components, Inc., PRODIMED ZI, SCW Medicath Ltd., SILMAG, Teleflex Inc., ZOLL Medical Corporation, Terumo Corporation, Vygon SA, Troge Medical GmbH, Vogt Medical Vertrieb GmbH. Pricing and purchase options Customized buying options are available to meet your exact research needs. Market Analysis Of Different Segments Covered in the Report Based on Product Type Non-Tunnelled Catheters Tunnelled Catheters Based on Property Non-Antimicrobial Catheters Antimicrobial Catheters Others Based on Design Multi Lumen Double Lumen Single Lumen Based on Composition Polyurethane Silicone Others Based on End-User Hospitals (Special Care Units, Intensive Care Units, and other hospital settings) Long-Term Care Facilities (LTCFs) Outpatient Facilities Ambulatory Surgical Clinics Dialysis Centers Regional Analysis North America U.S. Mexico Canada Rest of North America Europe Switzerland Russia France Germany U.K Finland Turkey Netherlands Belgium Spain Italy Rest of Europe Asia Pacific China India Indonesia South Korea Thailand Japan Singapore Malaysia Philippines Australia New Zealand Rest of APAC LAMEA Brazil Saudi Arabia Uruguay Argentina Rest of LAMEA Segments Analysis & Insights Based on Product Type, the 'Non-Tunnelled Catheters' segment dominated the market significantly in 2020 with a steady CAGR. The rise in the awareness of the usage of Non-Tunnelled Catheters during emergencies and an increase in the number of incisions across the world are driving the overall growth of this segment. Based on Property, the 'Antimicrobial Catheters' segment dominated the market with over 35.732% of the market share in 2020. An increased focus on the prevention of HAIs (Healthcare-Associated Infections) across the globe is propelling the growth of the market in this region. Based on Design, the 'Double Lumen' segment comprehensively dominated the market, with 17.832% of the overall market share in 2020. The total share of the Double-Lumen segment in the United States, Australia, Canada, China, and Japan together accounted for up to USD 161.134 Mn in 2020. The increase in the number of ARF (Acute renal failure) treatments in the ICUs is stimulating the overall market growth in this region. Based on Composition, the 'Silicone' segment dominated the market with a total share of more than 14.372% of the entire market in 2020. The silicone material catheters are mainly preferred globally due to their flexible nature and long-term usage as a tunnelled CVC (Central Venous Catheters). Based on End-User, the 'Hospitals' segment dominated the market significantly with a steady CAGR due to increased usage of CVCs in ICU and CICU (cardiac intensive care units) worldwide. Based on Region, North America comprehensively dominated the market in 2020 with a decent CAGR. The United States accounted for over 33.917% (i.e., USD 384.763 Mn) of the overall market share in 2020. The Asia-Pacific region held the fastest growth rate, with China accounting for up to a CAGR of 7.368%. In Europe, Germany held the highest share of the market with an overall CAGR of 5.137%, and the Rest of the European Market is estimated to reach a value of USD 223.135 Mn by 2030. Global Central Venous Catheter Market Competitive Landscape Analysis An overall competitive landscape analysis provides the most accurate information about the crucial competitors that exist globally. The comparison is performed based on market initiatives, total revenue generation, investment in R&D, company overview, company financials, market potential, company strengths and weaknesses, global presence, production capacity, production sites and facilities, etc. Amecath B. Braun Melsungen AG Boston Scientific Corporation AngioDynamics, Inc. BACTIGUARD Cook Medical, Inc. Smiths Medical Becton, Dickinson & Company Biosensors International Group Ltd. BARD Care ConMed Corporation Edwards Lifesciences Corporation Guangdong Baihe Medical Technology Co. Ltd. Intra Special Catheters GmbH ISO-MED, INC. Henan Tuoren Medical Device Co. Ltd. Kimal PLC Lepu Medical Technology (Beijing) Co. Ltd Medical Components, Inc. PRODIMED ZI SCW Medicath Ltd. SILMAG Teleflex Inc. ZOLL Medical Corporation Terumo Corporation Vygon SA Troge Medical GmbH Vogt Medical Vertrieb GmbH Recent Developments On Oct 2018, Interred Medical announced an agreement with Vygon to distribute the SecurAcath Subcutaneous Catheter Securement Device in France. It is especially for those children and adults who require CVCs for their surgeries. On Feb 2019, Smiths Medical launched Intra CVCs, which is a German product that offers safe, easy, and cost-effective treatment options to clinicians and patients. Also, the Intra CVC kit offers both Straight Needle and Y Needle Kits with a comprehensive range across the central venous catheter kits. On July 2021, Philips announced the first patient treatment with its brand-new FDA 510k-cleared real-time 3D intracardiac echocardiography catheters. It has the potential to improve the standard of care for electrophysiology procedures and heart diseases. Frequently Asked Question About This Report Which is the most leading End-User segment of the market? Based on End-User, the Hospitals segment comprehensively dominated the market with a steady CAGR across the globe. Which is the most dominant type of product in the market? Based on Product Type, the Non-Tunnelled Catheters segment dominated the market significantly in 2020 with a steady CAGR. Who are the essential players of the market? The most vital players of the market are Amecath, B. Braun Melsungen AG, Boston Scientific Corporation, AngioDynamics Inc, BACTIGUARD, Cook Medical Inc, Smiths Medical, Becton, Dickinson & Company, Biosensors International Group Ltd, BARD Care, ConMed Corporation, Edwards Lifesciences Corporation, Guangdong Baihe Medical Technology Co. Ltd, Intra Special Catheters GmbH, ISO-MED Inc, Henan Tuoren Medical Device Co. Ltd, Kimal PLC, Lepu Medical Technology (Beijing) Co. Ltd, Medical Components Inc, PRODIMED ZI, SCW Medicath Ltd, SILMAG, Teleflex Inc, ZOLL Medical Corporation, Terumo Corporation, Vygon SA, Troge Medical GmbH, and Vogt Medical Vertrieb GmbH. What are the most dominant and fastest regions of the market? Based on Region, North America comprehensively dominated the market in 2020 with a decent CAGR. The United States accounted for over 33.917% (i.e., USD 384.763 Mn) of the overall market share in 2020. The Asia-Pacific region held the fastest rate of growth, with China accounting for up to a CAGR of 7.368%. In Europe, Germany held the highest share of the market with an overall CAGR of 5.137%, and the Rest of the European Market is estimated to reach a value of USD 223.135 Mn by 2030. In terms of Composition, which is the most leading segment of the market? Based on Composition, the Silicone segment dominated the market with a total share of more than 14.372% of the entire market in 2020. What are the Central Venous Catheter market growth? The global Central Venous Catheter market is expected to grow at a compound annual growth rate (CAGR) of 5.48% from 2021 to 2030 to reach USD 1.93 Billion by 2030. How big is the Central Venous Catheter market? The global Central Venous Catheter market size was $1.18 Bn in 2021 and is predicted to reach $ 1.93 Bn by 2030, with a CAGR of 5.48%. Sources: https://www.heart.org/-/media/phd-files-2/science-news/2/2021-heart-and-stroke-stat-update/2021_heart_disease_and_stroke_statistics_update_fact_sheet_at_a_glance.pdf https://www.un.org/development/desa/en/news/population/our-world-is-growing-older.html https://www.bloomberg.com/press-releases/2018-10-08/interrad-medical-announces-agreement-with-vygon-to-distribute-securacath-in-france https://www.usa.philips.com/a-w/about/news/archive/standard/news/press/2021/20210701-philips-announces-first-patient-treated-with-its-new-real-time-3d-intracardiac-echocardiography-catheter-verisight-pro.html 1. Introduction 1.1. Study Objective 1.2. Market Definition 1.3. Study Scope 1.3.1. Markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. Market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at Market size by bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing Market Size by Top-Down Analysis 2.5. Market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 Market: Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 Market Summary 4. Industry Outlook 4.1 Market Snapshot 4.2 Global Central Venous Catheter Market 4.2.1 Market, 2020 – 2028 (USD Million) 4.3 Regional Business Analysis 4.3.1 Market, by Region, 2020 - 2030 (USD Million) 4.4 Product Type Analysis 4.4.1 Market, By Product Type, 2020 - 2030 (USD Million) 4.5 Property Business Analysis 4.5.1 Market, By Property, 2020 - 2030 (USD Million) 4.6 Design Analysis 4.6.1 Market, By Design, 2020 - 2030 (USD Million) 4.7 Composition Business Analysis 4.7.1 Market, By Composition, 2020 - 2030 (USD Million) 4.8 End-User 4.8.1 End-User Market, By Composition, 2020 - 2030 (USD Million) 4.9 Value Chain Analysis 4.10 Market Variable Analysis 4.10.1 Market Drivers Analysis 4.10.2 Market Restraints Analysis 4.11 Business Environment Analysis Tool 4.11.1 Market PEST analysis 4.11.2 Market Porter’s analysis 4.12 Penetration & Growth Prospect Mapping 5. Market Dynamics 5.1. Introduction 5.2. Market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 On Market 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. Technology Analysis 5.11.1. Trends in Technology (2014-2020) 5.11.2. Trends in Technology (2021-2028) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By region, By Countries) 6. Competitive & Vendor Landscape 6.1. Company Market Share Analysis 6.2. Manufacturers Manufacturing Sites, Area Served, End-User 6.3. Market Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Market: By Product Type Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2020-2030) 7.3. Non-Tunnelled Catheters 7.3.1. Non-Tunnelled Catheters Market, 2020 - 2030 (USD Million) 7.4. Tunnelled Catheters 7.4.1. Tunnelled Catheters Market, 2020 - 2030 (USD Million) 8. Market: By Property Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2020-2030) 8.3. Non-Antimicrobial Catheters 8.3.1. Non-Antimicrobial Catheters Market, 2020 - 2030 (USD Million) 8.4. Antimicrobial Catheters 8.4.1. Antimicrobial Catheters Market, 2020 - 2030 (USD Million) 8.5 Others 8.5.1 Others Market, 2020 - 2030 (USD Million) 9. Market: By Design Segment Analysis 9.1. Introduction 9.2. Sales Volume & Revenue Analysis (2020-2030) 9.3. Multi Lumen 9.3.1. Multi Lumen Market, 2020 - 2030 (USD Million) 9.4. Double Lumen 9.4.1. Double Lumen Market, 2020 - 2030 (USD Million) 9.5 Single Lumen 9.5.1 Single Lumen Market, 2020 - 2030 (USD Million) 10. Market: By Composition Segment Analysis 10.1. Introduction 10.2. Sales Volume & Revenue Analysis (2020-2030) 10.3. Polyurethane 10.3.1. Polyurethane Market, 2020 - 2030 (USD Million) 10.4. Silicone 10.4.1. Silicone Market, 2020 - 2030 (USD Million) 10.5 Others 10.5.1 Others Market, 2020 - 2030 (USD Million) 11. Market: By End-User Segment Analysis 11.1. Introduction 11.2. Sales Volume & Revenue Analysis (2020-2030) 11.3. Hospitals (Special Care Units, Intensive Care Units, and other hospital settings) 11.3.1. Hospitals (Special Care Units, Intensive Care Units, and other hospital settings) Market, 2020 - 2030 (USD Million) 11.4. Long-Term Care Facilities (LTCFs) 11.4.1. Long-Term Care Facilities (LTCFs) Market, 2020 - 2030 (USD Million) 11.5 Outpatient Facilities 11.5.1 Outpatient Facilities Market, 2020 - 2030 (USD Million) 11.5.1.1 Ambulatory Surgical Clinics Market, 2020 - 2030 (USD Million) 11.5.1.2 Dialysis Centers Market, 2020 - 2030 (USD Million) 12. Market: Regional Outlook 12.1 North America 12.1.1. North America Market, By End-User, 2020 - 2030 (USD Million) 12.1.4. North America Market, By Application, 2020 - 2030 (USD Million) 12.1.5. North America Market, by Country, 2020 - 2030 (USD Million) 12.1.4.1. U.S. 12.1.4.1.1. U.S. Market, By End-User, 2020 - 2030 (USD Million) 12.1.4.2. Canada 12.1.4.2.1. Canada Market, By End-User, 2020 - 2030 (USD Million) 12.1.4.2.2. Canada Market, By Region, 2020 - 2030 (USD Million) 12.1.4.2.3. Canada Market, by Applications, 2020 - 2030 (USD Million) 12.2. Europe 12.2.1. Europe Market, By End-User, 2020 - 2030 (USD Million) 12.2.2. Europe Market, by By Application, 2020 - 2030 (USD Million) 12.2.5. Europe Market, by country, 2020 - 2030 (USD Million) 12.2.4.1 U.K. 12.2.4.1.1. U.K. Market, By End-User, 2020 - 2030 (USD Million) 12.2.4.1.2. U.K. Market, By Applications, 2020 - 2030 (USD Million) 12.2.4.1.3. U.K. Market, by Region, 2020 - 2030 (USD Million) 12.2.4.2. Germany 12.2.4.2.1. Germany Market, By End-User, 2020 - 2030 (USD Million) 12.2.4.2.2. Germany Market, By Application, 2020 - 2030 (USD Million) 12.2.4.2.3. Germany Market, by Region, 2020 - 2030 (USD Million) 12.2.4.3. France 12.2.4.3.1. France Market, By End-User, 2020 - 2030 (USD Million) 12.2.4.3.2. France Market, By Region, 2020 - 2030 (USD Million) 12.2.4.3.3. France Market, by Application, 2020 - 2030 (USD Million) 12.2.4.4. Rest of Europe 12.2.4.4.1. Rest of Europe Market, By End-User, 2020 - 2030 (USD Million) 12.2.4.4.2. Rest of Europe Market, By Region, 2020 - 2030 (USD Million) 12.2.4.4.3. Rest of Europe Market, by Application, 2020 - 2030 (USD Million) 12.3. Asia Pacific 12.3.1. Asia Pacific Market, By End-User, 2020 - 2030 (USD Million) 12.3.2. Asia Pacific Market, By Application, 2020 - 2030 (USD Million) 12.3.5. Asia Pacific Market, by country, 2020 - 2030 (USD Million) 12.3.4.1. China 12.3.4.1.1. China Market, By End-User, 2020 - 2030 (USD Million) 12.3.4.1.2. China Market, By Region, 2020 - 2030 (USD Million) 12.3.4.1.3. China Market, by Application, 2020 - 2030 (USD Million) 12.3.4.2. India 12.3.4.2.1. India Market, By End-User, 2020 - 2030 (USD Million) 12.3.4.2.2. India Market, By Region, 2020 - 2030 (USD Million) 12.3.4.2.3. India Market, by Application, 2020 - 2030 (USD Million) 12.3.4.3. Japan 12.3.4.3.1. Japan Market, By End-User, 2020 - 2030 (USD Million) 12.3.4.3.3. Japan Market, by Application, 2020 - 2030 (USD Million) 12.3.4.4. South Korea 12.3.4.4.1. South Korea Market, By End-User, 2020 - 2030 (USD Million) 12.3.4.4.3. South Korea Market, by Application, 2020 - 2030 (USD Million) 12.3.4.5. Rest of ASIA PACIFIC 12.3.4.5.1. Rest of ASIA PACIFIC Market, By End-User, 2020 - 2030 (USD Million) 12.3.4.5.3. Rest of ASIA PACIFIC Market, by Application, 2020 - 2030 (USD Million) 12.4. Latin America 12.4.1. Latin America Market, By End-User, 2020 - 2030 (USD Million) 12.4.3. Latin America Market, by Application, 2020 - 2030 (USD Million) 12.4.4. Latin America Market, by country, 2020 - 2030 (USD Million) 12.4.4.1. Brazil 12.4.4.1.1. Brazil Market, By End-User, 2020 - 2030 (USD Million) 12.4.4.1.3. Brazil Market, by Application, 2020 - 2030 (USD Million) 12.4.4.2. Mexico 12.4.4.2.1. Mexico Market, By End-User, 2020 - 2030 (USD Million) 12.4.4.2.3. Mexico Market, by Application, 2020 - 2030 (USD Million) 12.4.4.3. Rest of the Latin America 12.4.4.3.1. Rest of the Latin America Market, By End-User, 2020 - 2030 (USD Million) 12.4.4.3.3. Rest of the Latin America Market, by Application, 2020 - 2030 (USD Million) 13. Competitive Landscape 13.1 Amecath. 13.1.1. Company overview 13.1.2. Financial performance 13.1.3. Product Portfolio Analysis 13.1.4. Business Strategy & Recent Development 13.2. B. Braun Melsungen AG. 13.2.1. Company overview 13.2.2. Financial performance 13.2.3. Product Portfolio Analysis 13.2.4. Business Strategy & Recent Development 13.3. Boston Scientific Corporation. 13.3.1. Company overview 13.3.2. Financial performance 13.3.3. Product Portfolio Analysis 13.3.4. Business Strategy & Recent Development 13.4. AngioDynamics, Inc. 13.4.1. Company overview 13.4.2. Financial performance 13.4.3. Product Portfolio Analysis 13.4.4. Business Strategy & Recent Development 13.5. BACTIGUARD. 13.5.1. Company overview 13.5.2. Financial performance 13.5.3. Product Portfolio Analysis 13.5.4. Business Strategy & Recent Development 13.6. Cook Medical, Inc. 13.6.1. Company overview 13.6.2. Financial performance 13.6.3. Product Portfolio Analysis 13.6.4. Business Strategy & Recent Development 13.7.3 Smiths Medical. 13.7.1. Company overview 13.7.2. Financial performance 13.7.3. Product Portfolio Analysis 13.7.4. Business Strategy & Recent Development 13.8. Becton, Dickinson & Company. 13.8.1. Company overview 13.8.2. Financial performance 13.8.3. Product Portfolio Analysis 13.8.4. Business Strategy & Recent Development 13.9. Biosensors International Group Ltd.. 13.9.1. Company overview 13.9.2. Financial performance 13.9.3. Product Portfolio Analysis 13.9.4. Business Strategy & Recent Development 13.10. BARD Care. 13.10.1. Company overview 13.10.2. Financial performance 13.10.3. Product Portfolio Analysis 13.10.4. Business Strategy & Recent Development 13.11. ConMed Corporation. 13.11.1. Company overview 13.11.2. Financial performance 13.11.3. Product Portfolio Analysis 13.11.4. Business Strategy & Recent Development 13.12. Edwards Lifesciences Corporation. 13.12.1. Company overview 13.12.2. Financial performance 13.12.3. Product Portfolio Analysis 13.12.4. Business Strategy & Recent Development 13.13. Guangdong Baihe Medical Technology Co. Ltd. 13.13.1. Company overview 13.13.2. Financial performance 13.13.3. Product Portfolio Analysis 13.13.4. Business Strategy & Recent Development 13.14. Intra Special Catheters GmbH. 13.14.1. Company overview 13.14.2. Financial performance 13.14.3. Product Portfolio Analysis 13.14.4. Business Strategy & Recent Development 13.15. ISO-MED, INC. 13.15.1. Company overview 13.15.2. Financial performance 13.15.3. Product Portfolio Analysis 13.15.4. Business Strategy & Recent Development 13.16. Kimal PLC. 13.16.1. Company overview 13.16.2. Financial performance 13.16.3. Product Portfolio Analysis 13.16.4. Business Strategy & Recent Development 13.17. Lepu Medical Technology (Beijing) Co. Ltd. 13.17.1. Company overview 13.17.2. Financial performance 13.17.3. Product Portfolio Analysis 13.17.4. Business Strategy & Recent Development 13.18. Medical Components, Inc. 13.18.1. Company overview 13.18.2. Financial performance 13.18.3. Product Portfolio Analysis 13.18.4. Business Strategy & Recent Development 13.19. PRODIMED ZI. 13.19.1. Company overview 13.19.2. Financial performance 13.19.3. Product Portfolio Analysis 13.19.4. Business Strategy & Recent Development 13.20. SCW Medicath Ltd. 13.20.1. Company overview 13.20.2. Financial performance 13.20.3. Product Portfolio Analysis 13.20.4. Business Strategy & Recent Development 13.21. SILMAG. 13.21.1. Company overview 13.21.2. Financial performance 13.21.3. Product Portfolio Analysis 10.15.4. Business Strategy & Recent Development 13.22. Teleflex Inc. 13.22.1. Company overview 13.22.2. Financial performance 13.22.3. Product Portfolio Analysis 13.22.4. Business Strategy & Recent Development 13.23. ZOLL Medical Corporation. 13.23.1. Company overview 13.23.2. Financial performance 13.23.3. Product Portfolio Analysis 13.23.4. Business Strategy & Recent Development 13.24. Terumo Corporation. 13.24.1. Company overview 13.24.2. Financial performance 13.24.3. Product Portfolio Analysis 13.24.4. Business Strategy & Recent Development 13.25. Vygon SA. 13.25.1. Company overview 13.25.2. Financial performance 13.25.3. Product Portfolio Analysis 13.25.4. Business Strategy & Recent Development 13.26. Troge Medical GmbH. 13.26.1. Company overview 13.26.2. Financial performance 13.26.3. Product Portfolio Analysis 13.26.4. Business Strategy & Recent Development 13.27. Vogt Medical Vertrieb GmbH. 13.27.1. Company overview 13.27.2. Financial performance 13.27.3. Product Portfolio Analysis 13.27.4. Business Strategy & Recent Development 13.28. Henan Tuoren Medical Device Co. Ltd. 13.28.1. Company overview 13.28.2. Financial performance 13.28.3. Product Portfolio Analysis 13.28.4. Business Strategy & Recent Development List of Tables (89 Tables) TABLE 1. MARKET, By Product Type, 2020-2030 (USD Million) TABLE 2. MARKET FOR Non-Tunnelled Catheters, BY REGION, 2020-2030 (USD Million) TABLE 3. MARKET FOR Tunnelled Catheters, BY REGION, 2020-2030 (USD Million) TABLE 4. MARKET, By Property, 2020-2030 (USD Million) TABLE 5. MARKET FOR Non-Antimicrobial Catheters, BY REGION, 2020-2030 (USD Million) TABLE 6. MARKET FOR Antimicrobial Catheters, BY REGION, 2020-2030 (USD Million) TABLE 7. MARKET FOR Others, BY REGION, 2020-2030 (USD Million) TABLE 8. MARKET, By Design, 2020-2030 (USD Million) TABLE 9. MARKET FOR Multi Lumen, BY REGION, 2020-2030 (USD Million) TABLE 10. MARKET FOR Double Lumen, BY REGION, 2020-2030 (USD Million) TABLE 11. MARKET FOR Single Lumen, BY REGION, 2020-2030 (USD Million) TABLE 12. MARKET, By Composition, 2020-2030 (USD Million) TABLE 13. MARKET FOR Polyurethane, BY REGION, 2020-2030 (USD Million) TABLE 14. MARKET FOR Silicone, BY REGION, 2020-2030 (USD Million) TABLE 15. MARKET FOR Others, BY REGION, 2020-2030 (USD Million) TABLE 16. MARKET, By End-User, 2020-2030 (USD Million) TABLE 17. MARKET FOR Hospitals (Special Care Units, Intensive Care Units, and other hospital settings), BY REGION, 2020-2030 (USD Million) TABLE 18. MARKET FOR Long-Term Care Facilities (LTCFs), BY REGION, 2020-2030 (USD Million) TABLE 19. MARKET FOR Outpatient Facilities, BY REGION, 2020-2030 (USD Million) TABLE 20. MARKET FOR Ambulatory Surgical Clinics, BY REGION, 2020-2030 (USD Million) TABLE 21. MARKET FOR Dialysis Centers, BY REGION, 2020-2030 (USD Million) TABLE 22. MARKET, BY REGION, 2020-2030 (USD Million) TABLE 23. NORTH AMERICA MARKET, BY COUNTRY, 2020-2030 (USD Million) TABLE 24. NORTH AMERICA MARKET, BY Product Type, 2020-2030 (USD Million) TABLE 25. NORTH AMERICA MARKET, By Property, 2020-2030 (USD Million) TABLE 26. NORTH AMERICA MARKET, BY Design, 2020-2030 (USD Million) TABLE 27. EUROPE MARKET, BY COUNTRY, 2020-2030 (USD Million) TABLE 28. EUROPE MARKET, By End-User, 2020-2030 (USD Million) TABLE 29. EUROPE MARKET, BY Design, 2020-2030 (USD Million) TABLE 30. ASIA-PACIFIC MARKET, BY COUNTRY, 2020-2030 (USD Million) TABLE 31. ASIA-PACIFIC MARKET, By End-User, 2020-2030 (USD Million) TABLE 32. ASIA-PACIFIC MARKET, BY Composition, 2020-2030 (USD Million) TABLE 33. LAMEA MARKET, BY COUNTRY, 2020-2030 (USD Million) TABLE 34. LAMEA MARKET, By End-User, 2020-2030 (USD Million) TABLE 35. LAMEA MARKET, BY Property, 2020-2030 (USD Million) TABLE 36. Amecath: COMPANY SNAPSHOT TABLE 37. Amecath: OPERATING SEGMENTS TABLE 38. B. Braun Melsungen AG: COMPANY SNAPSHOT TABLE 39. B. Braun Melsungen AG: OPERATING SEGMENTS TABLE 40. Boston Scientific Corporation: COMPANY SNAPSHOT TABLE 41. Boston Scientific Corporation: OPERATING SEGMENTS TABLE 42. AngioDynamics, Inc: COMPANY SNAPSHOT TABLE 43. AngioDynamics, Inc: OPERATING SEGMENTS TABLE 44. BACTIGUARD: COMPANY SNAPSHOT TABLE 45. BACTIGUARD: OPERATING SEGMENTS TABLE 46. Cook Medical, Inc: COMPANY SNAPSHOT TABLE 47. Cook Medical, Inc: OPERATING SEGMENTS TABLE 48. Smiths Medical: COMPANY SNAPSHOT TABLE 49. Smiths Medical: OPERATING SEGMENTS TABLE 50. Becton, Dickinson & Company: COMPANY SNAPSHOT TABLE 51. Becton, Dickinson & Company: OPERATING SEGMENTS TABLE 52. Biosensors International Group Ltd: COMPANY SNAPSHOT TABLE 53. Biosensors International Group Ltd: OPERATING SEGMENTS TABLE 54. BARD Care: COMPANY SNAPSHOT TABLE 55. BARD Care: OPERATING SEGMENTS TABLE 56. ConMed Corporation: COMPANY SNAPSHOT TABLE 57. ConMed Corporation: OPERATING SEGMENTS TABLE 58. Edwards Lifesciences Corporation: COMPANY SNAPSHOT TABLE 59. Edwards Lifesciences Corporation: OPERATING SEGMENTS TABLE 60. Guangdong Baihe Medical Technology Co. Ltd: COMPANY SNAPSHOT TABLE 61. Guangdong Baihe Medical Technology Co. Ltd: OPERATING SEGMENTS TABLE 62. Intra Special Catheters GmbH: COMPANY SNAPSHOT TABLE 63. Intra Special Catheters GmbH: OPERATING SEGMENTS TABLE 64. Henan Tuoren Medical Device Co. Ltd: COMPANY SNAPSHOT TABLE 65. Henan Tuoren Medical Device Co. Ltd: OPERATING SEGMENTS TABLE 66. Kimal PLC: COMPANY SNAPSHOT TABLE 67. Kimal PLC: OPERATING SEGMENTS TABLE 68. Lepu Medical Technology (Beijing) Co. Ltd: COMPANY SNAPSHOT TABLE 69. Lepu Medical Technology (Beijing) Co. Ltd: OPERATING SEGMENTS TABLE 70. Medical Components, Inc: COMPANY SNAPSHOT TABLE 71. Medical Components, Inc: OPERATING SEGMENTS TABLE 72. PRODIMED ZI: COMPANY SNAPSHOT TABLE 73. PRODIMED ZI: OPERATING SEGMENTS TABLE 74. SCW Medicath Ltd: COMPANY SNAPSHOT TABLE 75. SCW Medicath Ltd: OPERATING SEGMENTS TABLE 76. SILMAG: COMPANY SNAPSHOT TABLE 77. SILMAG: OPERATING SEGMENTS TABLE 78. Teleflex Inc: COMPANY SNAPSHOT TABLE 79. Teleflex Inc: OPERATING SEGMENTS TABLE 80. ZOLL Medical Corporation: COMPANY SNAPSHOT TABLE 81. ZOLL Medical Corporation: OPERATING SEGMENTS TABLE 82. Terumo Corporation: COMPANY SNAPSHOT TABLE 83. Terumo Corporation: OPERATING SEGMENTS TABLE 84. Vygon SA: COMPANY SNAPSHOT TABLE 85. Vygon SA: OPERATING SEGMENTS TABLE 86. Troge Medical GmbH: COMPANY SNAPSHOT TABLE 87. Troge Medical GmbH: OPERATING SEGMENTS TABLE 88. Vogt Medical Vertrieb GmbH: COMPANY SNAPSHOT TABLE89. Vogt Medical Vertrieb GmbH: OPERATING SEGMENTS List of Figures (26 Figures) Figure 1 Market: Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries: Market Figure 4 Research Methodology: Hypothesis Building Figure 5 Market: Product-Based Estimation Figure 6 Top 28 Companies with Highest No. Of Patent in Last 9 Years Figure 7 No. Of Patents Granted Per Year, 2019–2020 Figure 8 Import Data for , By Country, 2016–2020 (USD Thousand) Figure 9 Export Data for , By Country, 2016–2020 (USD Thousand) Figure 10 Data Triangulation Methodology Figure 11 Market, By Product Type, 2019 vs. 2025 (USD Million) Figure 12 Market Share, By Property, 2019 vs. 2025 Figure 13 Market, By Design, 2019 vs. 2025 (USD Million) Figure 14 Market Share, By Composition, 2019 vs. 2025 Figure 15 Market, By End-User, 2019 vs. 2025 (USD Million) Figure 16 Geographical Snapshot of the Market Figure 17 Non-Tunnelled Catheters to Witness Higher CAGR in Market for Product Type Segment during Forecast Period. Figure 18 Antimicrobial Catheters to Witness Higher CAGR in Market for Property Segment during Forecast Period. Figure 19 Double Lumen to Witness Higher CAGR in Market for Design Segment during Forecast Period. Figure 20 Silicone to Witness Higher CAGR in Market for Composition Segment during Forecast Period. Figure 21 Hospitals to Witness Higher CAGR in Market for End-User Segment during Forecast Period. Figure 22 North America Accounted for the Largest Share of the Market, By Regional Basis, in 2019 Figure 23 Market: Drivers, Restraints, Opportunities, and Challenges Figure 24 North America: Market Snapshot Figure 25 Asia Pacific: Market Snapshot Figure 26 Vendor Dive: Evaluation Overview